Equitable Holdings’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$479K Sell
4,997
-10,487
-68% -$1.08M ﹤0.01% 1347
2026
Q1
$1.26M Buy
15,484
+1,015
+7% +$96.7K 0.01% 895
2025
Q4
$1.17M Buy
14,469
+205
+1% +$17.6K 0.01% 803
2025
Q3
$1.25M Buy
14,264
+2,910
+26% +$260K 0.01% 772
2025
Q2
$943K Buy
11,354
+2,386
+27% +$199K 0.01% 813
2025
Q1
$752K Buy
8,968
+1,953
+28% +$182K 0.01% 794
2024
Q4
$646K Buy
7,015
+1,424
+25% +$137K 0.01% 806
2024
Q3
$519K Buy
5,591
+2,067
+59% +$179K 0.01% 852
2024
Q2
$290K Buy
+3,524
New +$259K ﹤0.01% 1002

Other funds holding LMAT

Equitable Holdings's LMAT Position: Q2 2026 in Review

Equitable Holdings reduced its LeMaitre Vascular (LMAT) stake by 68% in Q2 2026, selling an estimated $1.08M and leaving 4,997 shares worth $479K. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Equitable Holdings first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.26M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Equitable Holdings held 4,997 shares of LeMaitre Vascular worth $479K as of Q2 2026.
  • Equitable Holdings sold 10,487 LeMaitre Vascular shares in Q2 2026, an estimated $1.08M.
  • LeMaitre Vascular made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1347 holding.
  • Equitable Holdings first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
  • Equitable Holdings's LeMaitre Vascular position peaked at $1.26M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.